Apoptotic volume decrease and nitric oxide.

Carl D Bortner

doi:10.1016/j.tox.2004.11.024

Home/Archive/PubMed

PubMed · 15691586

Apoptotic volume decrease and nitric oxide.

Carl D Bortner

View original source ↗Export metadata ↓

Abstract

Apoptosis is a physiological cell death process whose well-defined characteristics distinguish it from more accidental cell death processes. The loss of cell volume, or cell shrinkage, recently termed apoptotic volume decrease (AVD), is considered a hallmark of the apoptotic process. The activation and/or repression of the AVD process has been shown to be quite complex during apoptosis, with the involvement of multiple ionic transport mechanisms acting in both a cell type and stimulus specific manner. Similarly, the role of nitric oxide (NO) during apoptosis has also been shown to be just as complex, specifically in its ability to either induce and/or prevent apoptosis. This review examines current evidence for a link between AVD and NO and how they may interact during the programmed cell death process.

Explore related subjects

Actins Animals Apoptosis Cell Size Cytoskeleton Humans Nitric Oxide Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Carl D Bortner. 2005-03-15. Apoptotic volume decrease and nitric oxide.. https://doi.org/10.1016/j.tox.2004.11.024

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2009

Nap1-mediated actin remodeling is essential for mammalian myoblast fusion.

Myoblast fusion is crucial for the formation, growth, maintenance and regeneration of healthy skeletal muscle. Unfortunately, the molecular machinery, cell behaviors, and membrane and cytoskeletal remodeling events that govern fusion and myofiber formation remain poorly understood. Using time-lapse imaging approaches on mouse C2C12 myoblasts, we identify discrete and specific molecular events at myoblast membranes during fusion and myotube formation. These events include rearrangement of cell shape from fibroblast to spindle-like morphologies, changes in lamellipodial and filopodial extensions during different periods of differentiation, and changes in membrane alignment and organization during fusion. We find that actin-cytoskeleton remodeling is crucial for these events: pharmacological inhibition of F-actin polymerization leads to decreased lamellipodial and filopodial extensions and to reduced myoblast fusion. Additionally, shRNA-mediated inhibition of Nap1, a member of the WAVE actin-remodeling complex, results in accumulations of F-actin structures at the plasma membrane that are concomitant with a decrease in myoblast fusion. Our data highlight distinct and essential roles for actin cytoskeleton remodeling during mammalian myoblast fusion, provide a platform for cellular and molecular dissection of the fusion process, and suggest a functional conservation of Nap1-regulated actin-cytoskeleton remodeling during myoblast fusion between mammals and Drosophila.

Actins↗

PubMed2007

Benzyl butyl phthalate influences actin distribution and cell proliferation in rat Py1a osteoblasts.

We previously reported that transient administration of phthalates induced actin cytoskeleton disruption in Py1a osteoblasts. However, the mechanism of this transient effect was not elucidated. In this study we provided evidence that the actin cytoskeletal re-established conditions are dependent on new actin expression and synthesis. To assess the role of phthalates in modulating the distribution of actin, confocal and electron microscopy studies were carried out. Results indicated a modification of actin distribution after phthalate administration. In addition, a relation with the nucleoskeletal component lamin A supports the hypothesis that phthalates may participate in regulatory cell processes involving actin in Py1a osteoblasts. The present study also supports the mitogenic effects of phthalates, which involve microfilament disruption, nuclear actin and lamin A. In particular, the increased levels of cyclin D3, which in mammalian cells plays a critical role in G1 to S transition and is a putative proto-oncogene in benzyl butyl phthalate treated cells, suggested a possible effect of the endocrine disruptor in cancer processes.

Actins↗

PubMed2007

Tissue-specific expression of Riken 2810430M08 and its function in T-cell immune responses.

Riken 2810430M08 is a gene with unknown functions. According to in situ hybridization (ISH), it presented a pattern of temporal expression, peaking in the mid-gestation (embryonic Days e9-e14) stage in most tissues. In the late-gestation stage and during the adulthood, Riken 2810430M08 was expressed in some tissues with and without a robust proliferation program. Thus, the gene might have important functions that are related and unrelated to proliferation. Its expression was induced after T-cell receptor stimulation in T cells. However, transgenic mice with actin promoter-driven expression of Riken 2810430M08 showed normal in vitro and in vivo T cells responses, such as fetal thymus development, adult T cells activation marker expression, lymphokine secretion, proliferation and migration, and delayed type hypersensitivity (DTH). The expression of Riken 2810430M08 during ontogeny has provided useful clues for further investigation. Additional studies are warranted to examine its role in immune and other systems.

Actins↗